Skip to main content
. 2022 Mar 28;74(5):766–775. doi: 10.1002/art.42030

Figure 2.

Figure 2

Studies identified in the systematic literature review and meta‐analysis in which the risk of COVID‐19 among populations of patients with rheumatic and musculoskeletal diseases (RMDs) compared to those without RMDs was reported. The risk of COVID‐19 is assessed as risk ratios (RRs) with 95% confidence intervals (95% CIs). Color figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/doi/10.1002/art.42030/abstract.